Structures predicted by homology modelling with Robetta or modelled de-novo with evolutionary constraints using GREMLIN and Rosetta.
Filter list by:
| Model | Method | Target | Status | Annotation | Organism | Community |
|---|---|---|---|---|---|---|
| IPD_10491 | comparative modelling | MygeA.00039.a | target approved | Methionine aminopeptidase (MG_172) | Mycoplasma genitalium | internal |
| IPD_88301 | comparative modelling | MygeA.19933.a | target approved | Methionine--tRNA ligase (MG_021) | Mycoplasma genitalium | internal |
| IPD_88277 | comparative modelling | MygeA.01059.a | target approved | Methionyl-tRNA formyltransferase (MG_365) | Mycoplasma genitalium | internal |
| IPD_2692 | comparative modelling | LpboA.19696.a | purified | Methyltransferase | Leptospira borgpetersenii | request |
| IPD_81202 | comparative modelling | MygeA.19975.a | cloned | MgpA Bifunctional oligoribonuclease and PAP phosphatase NrnA (MG190) (MG_190) | Mycoplasma genitalium | interest |
| IPD_81919 | comparative modelling | BuamA.00098.a | in PDB | Molybdopterin biosynthesis MoaE protein | Burkholderia ambifaria | internal |
| IPD_3062 | comparative modelling | MygeA.01250.a | target approved | NAD kinase (MG_128) | Mycoplasma genitalium | internal |
| IPD_3077 | comparative modelling | MygeA.00025.a | target approved | NH(3)-dependent NAD(+) synthetase (MG_383) | Mycoplasma genitalium | internal |
| IPD_15727 | comparative modelling | BewuA.18651.a | purified | Nucleoprotein (N) | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
| IPD_2695 | comparative modelling | LpboA.00118.a | diffraction | Nucleoside-diphosphate-sugar pyrophosphorylase | Leptospira borgpetersenii | request |
| IPD_88380 | comparative modelling | MygeA.20187.a | target approved | Oligoendopeptidase F homolog (MG_183) | Mycoplasma genitalium | internal |
| IPD_10574 | comparative modelling | MygeA.10014.d | target approved | Oligopeptide transport ATP-binding protein OppD (MG_079) | Mycoplasma genitalium | internal |
| IPD_88298 | comparative modelling | MygeA.19932.d | target approved | Oligopeptide transport ATP-binding protein OppF (MG_080) | Mycoplasma genitalium | internal |
| IPD_14008 | comparative modelling | MygeA.20063.a | target approved | Oligopeptide transport system permease protein OppB (MG_077) | Mycoplasma genitalium | internal |
| IPD_2675 | comparative modelling | LpinA.17356.a | purified | OppA | Leptospira interrogans | request |
| IPD_15671 | comparative modelling | BewuA.18928.a | purified | orf1ab polyprotein ExoN (Guanine-N7 methyltransferase) (nsp14) | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
| IPD_15672 | comparative modelling | BewuA.18928.a | in PDB | orf1ab polyprotein NendoU (Uridylate-specific endoribonuclease) (nsp15) | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
| IPD_15661 | comparative modelling | BewuA.18928.a | selected | orf1ab polyprotein nsp1 | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
| IPD_15669 | comparative modelling | BewuA.18928.a | purified | orf1ab polyprotein nsp10 | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
| IPD_15673 | comparative modelling | BewuA.18928.a | purified | orf1ab polyprotein nsp16 (2prime-O-methyltransferase) | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
| IPD_15733 | comparative modelling | BewuA.18928.a | selected | orf1ab polyprotein nsp4 | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
| IPD_15666 | comparative modelling | BewuA.18928.a | purified | orf1ab polyprotein nsp7 | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
| IPD_15667 | comparative modelling | BewuA.18928.a | purified | orf1ab polyprotein nsp8 | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
| IPD_15668 | comparative modelling | BewuA.18928.a | purified | orf1ab polyprotein nsp9 | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
| IPD_15732 | comparative modelling | BewuA.18928.a | target approved | orf1ab polyprotein PL-PRO (Papain-like proteinase) (nsp3) | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |